Mizuho raises target for UnitedHealth Group stock to USD 500
Published on 10/26/2026 at 16:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and earnings
- Mizuho raised its UnitedHealth Group target from USD 493.00 to USD 500.00 on October 22, 2026.
- Third-quarter 2026 revenue reached USD 112.70 billion, while adjusted earnings per share came to USD 4.69.
- UnitedHealth Group stock costs EUR 368.80 at Lang & Schwarz on October 26, 2026 at 4:42 p.m. CET, 2.59 percent below the Xetra close of October 23, 2026.
- The stock had a USD 255.97 to USD 461.62 52-week range as of October 26, 2026.
UnitedHealth Group (ISIN US91324P1021) faces a new USD 500.00 price target from Mizuho, up from USD 493.00, while the target sits 21.45 percent above the USD 411.71 NYSE price at 11:52 a.m. ET on October 26, 2026. MarketBeat reported the analyst action on October 22, 2026. UnitedHealth Group stock was trading at EUR 368.80 at Lang & Schwarz on October 26, 2026 at 4:42 p.m. CET, down 2.59 percent versus the Xetra close of October 23, 2026 at EUR 378.60.
Revenue reached USD 112.70 billion
The latest operating picture came from the third quarter of 2026. UnitedHealth Group reported revenue of USD 112.70 billion, earnings from operations of USD 6.60 billion and adjusted earnings per share of USD 4.69 on October 13, 2026. Its GAAP earnings were USD 4.56 per share. UnitedHealth Group also raised its full-year 2026 adjusted earnings outlook to at least USD 20.50 per share from a previous range of USD 19.50 to USD 20.00.
CNBC reported that adjusted earnings exceeded the USD 4.14 consensus estimate, while revenue topped the USD 111.40 billion estimate. Revenue nevertheless declined from USD 113.16 billion in the third quarter of 2025, making cost control more important than headline growth.
Stock stays below its yearly high
UnitedHealth Group had a USD 255.97 to USD 461.62 52-week range as of October 26, 2026. The Lang & Schwarz price was 20.11 percent below the USD 461.62 high, while the current market capitalization was USD 369.5 billion and the trailing price-to-earnings ratio was 23.48.
How do peers compare?
Comparison with peers
UnitedHealth Group: down 2.59 percent versus the Xetra close, trailing price-to-earnings ratio 23.48, market capitalization USD 369.5 billion.
Cigna: up 0.01 percent on October 26, 2026, trailing price-to-earnings ratio 12.70, market capitalization USD 81.1 billion.
Elevance Health: down 1.77 percent on October 26, 2026, trailing price-to-earnings ratio 18.43, market capitalization USD 93.7 billion.
Price and target remain in view
Mizuho's revised target gives the analyst view a concrete valuation marker, but the third-quarter revenue decline shows why the stock's recovery still depends on operating execution. The next earnings-related milestone is the company's third-quarter report dated October 13, 2026, which remains the latest reported period.
UnitedHealth Group stock was trading at EUR 368.80 at Lang & Schwarz on October 26, 2026 at 4:42 p.m. CET, 2.59 percent below the Xetra close of October 23, 2026 at EUR 378.60. The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.
UnitedHealth Group market data
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- Ticker: UNH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 26, 2026, 4:42 p.m. CET): EUR 368.80
- Change versus Xetra close: minus 2.59 percent
- Xetra close (October 23, 2026): EUR 378.60
- Market capitalization: USD 369.5 billion (as of October 26, 2026)
- 52-week range: USD 255.97-461.62 (as of October 26, 2026)
- Sector / Industry: Healthcare / Medical - Healthcare Plans
Market context: Market report S&P 500.
